Illinois Municipal Retirement Fund Sells 1,735 Shares of Mettler-Toledo International, Inc. $MTD

Illinois Municipal Retirement Fund reduced its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 21.2% during the 2nd quarter, HoldingsChannel reports. The firm owned 6,461 shares of the medical instruments supplier’s stock after selling 1,735 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Mettler-Toledo International were worth $7,590,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in MTD. Acadian Asset Management LLC increased its holdings in shares of Mettler-Toledo International by 12.3% during the second quarter. Acadian Asset Management LLC now owns 2,823 shares of the medical instruments supplier’s stock worth $3,312,000 after buying an additional 310 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Mettler-Toledo International by 5.0% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 39,762 shares of the medical instruments supplier’s stock valued at $46,709,000 after acquiring an additional 1,896 shares during the last quarter. Aviva PLC lifted its stake in Mettler-Toledo International by 5.3% in the second quarter. Aviva PLC now owns 16,014 shares of the medical instruments supplier’s stock valued at $18,812,000 after buying an additional 799 shares during the period. Los Angeles Capital Management LLC raised its holdings in Mettler-Toledo International by 82.7% in the second quarter. Los Angeles Capital Management LLC now owns 550 shares of the medical instruments supplier’s stock worth $646,000 after purchasing an additional 249 shares during the period. Finally, Penserra Capital Management LLC raised its position in shares of Mettler-Toledo International by 10.7% during the second quarter. Penserra Capital Management LLC now owns 114 shares of the medical instruments supplier’s stock worth $133,000 after purchasing an additional 11 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

MTD has been the subject of a number of research reports. Evercore ISI increased their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. JPMorgan Chase & Co. boosted their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Bank of America raised their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Finally, Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,406.50.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,446.25 on Wednesday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,462.09. The company has a market cap of $29.79 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 4.19 and a beta of 1.41. The firm has a 50 day simple moving average of $1,326.50 and a 200 day simple moving average of $1,243.39.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gerry Keller sold 165 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.